CMS Is a Step Closer to Saying How It Will Fix Medicare Drug Payment Cuts for 340B Hospitals

OMB

CMS sent its proposed remedy for illegal Medicare Part B drug payment cuts for 340B hospitals to the White House for clearance to be released.

The U.S. Centers for Medicare & Medicaid Services has sent its proposed remedy for almost five years of illegal Medicare [...]

Continue Reading

CMS Proposes Rules That Addresses 340B Duplicate Discounts in Medicaid Managed Care

CMS

CMS proposes adding information to Medicaid managed care beneficiaries' insurance cards to facilitate 340B duplicate discount prevention.

The U.S. Centers for Medicare & Medicaid Services wants to make Medicaid managed care organizations use Medicaid-specific codes and group [...]

Continue Reading
Industry Insights Logo

How 340B Covered Entities are Disrupting the PBM and Preferred Pharmacy Landscape for Community Health Plans

SPONSORED CONTENT The 340B drug pricing program, which allows eligible healthcare providers known as covered entities to purchase medications at [...]

Continue Reading

340B Providers Don’t Systematically Over-Prescribe Brand Drugs for Profit, JAMA Study Says

JAMA

Research published in JAMA "found no meaningful difference in overall generic prescribing rates" between 340B and non-340B providers.

340B-eligible providers prescribe generic drugs at the same overall rate as non-340B providers, a study published in JAMA Health Forum [...]

Continue Reading

Arkansas 340B Contract Pharmacy Law Trespasses on Federal “Closed System,” PhRMA Tells Court

PhRMA v. McClain

Arkansas' 340B contract pharmacy law has no place in the federal 340B “closed system,” PhRMA told a federal appeals court.

Arkansas’ 340B contract pharmacy law, for now the only state law of its kind, has no place in the federal [...]

Continue Reading

340B Report Publisher and CEO: Is a Contract Pharmacy Breakthrough at Hand?

Breakthrough

Hospital groups' decision to back federal 340B contract pharmacy legislation could be a long-awaited breakthrough, 340B Report Publisher and CEO Ted Slafsky says.

Hospital groups’ decision to support letting Congress end the 340B contract pharmacy standoff could be the breakthrough the field has [...]

Continue Reading

House GOP Rejects Democrats’ Push to Link 340B Transparency and Contract Pharmacy

E&C 340B

House E&C Democrat Scott Peters (Calif.) spoke in favor of, and fellow Democrat Debbie Dingell (Mich.) spoke against, a Republican bill to impose reporting requirements on 340B DSH hospitals.

Congressional GOP backers of federal reporting requirements for 340B hospitals yesterday rejected Democratic arguments that fairness dictates that those requirements [...]

Continue Reading

340B Grantees Need More Scrutiny as Drug Margins Rise, Gilead-funded Study Says

Gilead BGR study

340B contract pharmacy arrangements rose 252% for grantee covered entities between 2017 to 2022 compared to 194% for hospitals, a new drug company-funded study found.

Health centers and other federal grantees’ 340B savings and how they use them need more scrutiny, as these covered entities [...]

Continue Reading

340B Advocacy Group CV340B Plans March on Capitol Hill July 12

CV340B

Community Voices for 340B (CV340B) on July 12 is holding its second annual Defend 340B March on Capitol Hill. The first was in August 2022.

340B grassroots group Community Voices for 340B (CV340B) has announced plans to hold its second annual Defend 340B March on [...]

Continue Reading
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live

Sliding Sidebar

Link to spotlight on Sean Hall of Visante

Article Archives